Coelho Rogerio Vivaldi, Director at Crinetics Pharmaceuticals, sold CRNX on Jul 2, 2026
Prices as of Sep 1 · price update delayed · Every feed →
▼ SELL$120K3,000 shares at $40.00Coelho Rogerio Vivaldi DirectorCRNX Crinetics Pharmaceuticals, Inc.
- Traded
- Jul 2, 2026
- Disclosed
- Jul 7, 2026
- Filed
- 5 days after the trade · late
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
CRNX since disclosure
+1.7%
after the sale
Similar stocks (XLV) since disclosure
+4.4%
XLV — its sector index fund
Change in closing price from Jul 7, 2026 (the first trading day on or after disclosure) to Sep 1, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.